Vireo Growth Crecimiento futuro
Future controles de criterios 0/6
Vireo Growth's revenue is forecast to decline at 1.4% per annum.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Pharmaceuticals | 54.4% |
| Tasa de crecimiento de los ingresos | -1.4% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 07 Aug 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Oct 12
Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Aug 10Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost
Jun 01Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company
Apr 06Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump
Feb 01Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt
Dec 14Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?
Jul 14Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?
Mar 19Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?
Jan 25Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 96 | N/A | N/A | -11 | 1 |
| 12/31/2024 | 97 | N/A | N/A | -6 | 1 |
| 6/30/2024 | 98 | -17 | -8 | 0 | N/A |
| 3/31/2024 | 93 | -24 | -5 | 2 | N/A |
| 12/31/2023 | 88 | -26 | -7 | -1 | N/A |
| 9/30/2023 | 83 | -34 | -11 | -7 | N/A |
| 6/30/2023 | 77 | -37 | -15 | -10 | N/A |
| 3/31/2023 | 78 | -36 | -19 | -15 | N/A |
| 12/31/2022 | 75 | -42 | -23 | -18 | N/A |
| 9/30/2022 | 69 | -43 | -28 | -20 | N/A |
| 6/30/2022 | 64 | -41 | -34 | -23 | N/A |
| 3/31/2022 | 57 | -41 | -47 | -32 | N/A |
| 12/31/2021 | 54 | -34 | -49 | -31 | N/A |
| 9/30/2021 | 53 | -22 | -42 | -23 | N/A |
| 6/30/2021 | 52 | -13 | -39 | -21 | N/A |
| 3/31/2021 | 50 | -22 | -26 | -13 | N/A |
| 12/31/2020 | 49 | -23 | -19 | -11 | N/A |
| 9/30/2020 | 48 | -63 | -27 | -22 | N/A |
| 6/30/2020 | 42 | -78 | -30 | -25 | N/A |
| 3/31/2020 | 36 | -62 | -35 | -28 | N/A |
| 12/31/2019 | 30 | -57 | -35 | -27 | N/A |
| 9/30/2019 | 25 | -17 | -26 | -19 | N/A |
| 6/30/2019 | 22 | -4 | -22 | -17 | N/A |
| 3/31/2019 | 21 | -4 | -13 | -10 | N/A |
| 12/31/2018 | 18 | -3 | -11 | -9 | N/A |
| 9/30/2018 | 16 | -2 | -13 | -6 | N/A |
| 12/31/2017 | 11 | 0 | N/A | -1 | N/A |
| 12/31/2016 | 4 | 6 | N/A | -4 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if VREO's forecast earnings growth is above the savings rate (2.2%).
Beneficios vs. Mercado: Insufficient data to determine if VREO's earnings are forecast to grow faster than the Canadian market
Beneficios de alto crecimiento: Insufficient data to determine if VREO's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: VREO's revenue is expected to decline over the next 3 years (-1.4% per year).
Ingresos de alto crecimiento: VREO's revenue is forecast to decline over the next 3 years (-1.4% per year).
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if VREO's Return on Equity is forecast to be high in 3 years time